Ross Pinkerton

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

Catherine Patte, Anne Aupérin, Mary Gerrard et al. · Blood · 2006 · 427 citations · Full text

Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B‐cell non‐Hodgkin’s lymphoma: results of the FAB/LMB 96 international study*

Mary Gerrard, Mitchell S. Cairo, Claire Weston et al. · British Journal of Haematology · 2008 · 198 citations

Hematological Malignancy, Lymphoid Neoplasia, B Nhl +15

Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study

Mitchell S. Cairo, Richard Sposto, Mary Gerrard et al. · Journal of Clinical Oncology · 2012 · 181 citations · Full text

European Intergroup Studies (MMT4-89 and MMT4-91) on Childhood Metastatic Rhabdomyosarcoma: Final Results and Analysis of Prognostic Factors

Modesto Carli, Raffaella Colombatti, Odile Oberlin et al. · Journal of Clinical Oncology · 2004 · 178 citations

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

Ruth Ladenstein, Thierry Philip, Christine Lasset et al. · Journal of Clinical Oncology · 1998 · 166 citations